II. BIOLOGY AND DIAGNOSIS

SEMINARS

(1) Cell Interaction and Cancer
Kyoto, Japan, November 5-7, 1981
Organizers: Ira Pastan
Yoji Ikawa
Participants: U.S.-5 ; Japan- 12

(2) Analysis of the Mechanisms for Induction of Tumor-Specific Immunity and Experimental Approaches to Tumor-Immunoprophylaxis and Therapy
Boston, U.S.A., November 9-11, 1981
Organizers: Richard J . Hodes
Toshiyuki Hamaoka
Participants: U.S.-8; Japan-8

(3)Application of Cytology Automation in Cancer Cytology and Cell Biology
Hakone, Japan, March 7-9, 1982
Organizers: Myron R. Melamed
Yoshio Tenjin
Participants: U.S.-6; Japan-16

EXCHANGE OF SCIENTISTS

(1) Dr. Ulf R. Rapp, Acting Chief, Viral Pathology Section, Laboratory of Viral Carcinogenesis, National Cancer Institute, Bethesda
Dates: February 15 to February 27, 1982
Host Scientist: Dr. Yoji Ikawa, Dept. of Viral Oncology, Japanese Foundation for Cancer Research, Tokyo
Subject: Use of MuLV for the transduction of cell derived tumor genes

(2) Dr. Ira H. Pastan, Chief, Laboratory of Molecular Biology, DCBD, National Cancer Institute, Bethesda
Dates: November 2 to November 8, 1981
Host Scientist: Dr. Shigetada Nakanishi, Faculty of Medicine, Kyoto University
Subject: Cell-cell interactions

(3) Dr. Samuel Barondes, Professor, Department of Psychiatry, School of Medicine, University of California, San Diego
Dates: November 2 to November 8, 1981
Host Scientist: Dr. Ikuo Takeuchi, Faculty of Science, Kyoto University
Subject: Cell-cell adhesion and slime mold development

(4) Dr. Irving L. Weissman, Associate Professor, Department of Pathology, Stanford University
Dates: October 26 to November 9, 1981
Host Scientist: Dr. Yoji Ikawa, Dept. of Viral Oncology, Japanese Foundation for Cancer Research, Tokyo
Subjects: B lymphocyte maturation

(5) Dr. Masatoshi Takeichi, Associate Professor, Department of Biophysics, Faculty of Science, Kyoto University
Dates: June 20 to July 10, 1981
Host Scientist: Dr. Kenneth M. Yamada, Membrane Biochemistry Section, National Cancer Institute, Bethesda
Subject: Adhesion and recognition of cancer cells

(6) Dr. Toshiyuki Hamaoka, Professor, Institute for Cancer Research, Osaka University Medical School
Dates: May 19 to June 5, 1981
Host Scientist: Dr. Mark I, Greene, Harvard Medical School
Subject: Anti-TRF acceptorsite(s) antibody which substitutes for TRF activity in triggering of B lymphocytes

(7) Dr. Ichiro Azuma, Professor, Research Institute of Immunology, Hokkaido University
Dates: March 27 to April 25, 1982
Host Scientist: Dr. Ronald Herberman, Frederick Cancer Research Center
Subject: Cancer immunotherapy

(8) *Dr. Kyoichi Kano, Professor, Department of Microbiology, School of Medicine, State University of New York at Buffalo
Dates: January 1 to June 30, 1981
Host Scientist: Dr. Toshihiko Horiuchi, The University of Tokyo
Subject: Studies on heterophile (Paul-Burnell) antigen-antibody in Japanese patients with virus malignancies

(*Exchange Scientist of JFY 1980)